There is a growing interest within the medical community in the use of psychedelic therapies to treat conditions ranging from depression and PTSD to anxiety and eating disorders. New research led by McGill University and published in The Lancet Child & Adolescent Health has found that while adolescents under 18 might also benefit from these types of treatments, they have been excluded from current clinical research in the field due to ethical, legal and regulatory concerns.
This article was originally published on MedicalXpress.com
